Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
Toronto (Oct. 24, 2006) - The emerging field of regenerative medicine aims to use the power of stem cells to repair, replace or regenerate damaged or injured tissues or organs, offering great promise for the treatment of a broad spectrum of diseases for which there are limited or no treatments, say McEwen Centre for Regenerative Medicine scientists who will speak Wednesday, October 25, 2006 at an afternoon symposium that launches the McEwen Centre for Regenerative Medicine at the University Health Network, a fully affiliated teaching hospital of the University of Toronto.
The symposium is chaired by the stellar team of Dr. John Dick, a Senior Scientist, Cellular and Molecular Biology, Toronto General Research Institute and Dr. Gordon Keller, the newly-appointed Director of the McEwen Centre. Dr. Keller, a pioneer inembryonic stem cell research, was identified as one of the top six medical minds that New York didn't want to lose in the Jan. 3 issue of New York magazine.
"Our goal is to develop novel therapies to regenerate damaged tissues and organs in chronic diseases and conditions such as Parkinson's, spinal cord injury, stroke, heart disease, leukemia and diabetes," said Dr. Keller, adding that ,"Our team of scientists and clinicians with diverse areas of expertise in stem cell research, biology, cancer research and organ repair are part of an outstanding science research base that exists in this city."
Dr. Keller explained that stem cells, immature cells which do not yet have a specialized function, have the unusual ability to form cells of any tissue in the body and that "the capacity of stem cells to give rise to many different cell types opens the door for developing new approaches for the treatment of various diseases."
Wednesday's symposium will bring together 10 internationally renowned scientists who will speak on a broad range of topics such as "Getting to the Root of Cancer", the "Regenerative Capacity of the Heart", the "Repair and Regeneration of the Injured Spinal Cord" and the use of regenerative techniques to improve lung function.
The keynote speech will be delivered by leading Harvard Medical School stem cell researcher Dr. George Daley, Associate Director of the Stem Cell/Developmental Biology Program at Children's Hospital Boston on "Stem Cells in Disease and Regenerative Medicine". Dr.Daley's address is open to the media and scheduled from 4:00 – 4:45 pm in the Medical and Related Sciences (MaRS) Auditorium. Dr. Daley's research pertains to leukemia and genetic diseases of the blood, and is aimed at translating insights in stem cell biology into cellular therapies. Dr. Daley is currently heading up one of two research teams at Harvard, attempting to create the world's first cloned human embryonic stem cells.
Dr. Daley's laboratory reported the first successful application of therapeutic cloning of embryonic stem cells to treat genetic disease in a mouse model of immune deficiency. Additionally, his lab was responsible for the first creation of functional sperm cells from embryonic stem cells, work that was cited by Science magazine as a "Top Ten" breakthrough for 2003.
Other symposium highlights include:
The McEwen Centre for Regenerative Medicine was established in 2003 with a generous donation from Rob and Cheryl McEwen. Its mission is to be a catalyst for regenerative medicine research by facilitating collaborations and promoting research and awareness in the field of regenerative medicine. The McEwen's Centre ultimate goal is to accelerate the development of better, more effective treatments for life-threatening conditions such as heart disease, diabetes, respiratory disease and spinal cord injury. The McEwen Centre for Regenerative Medicine is fully affiliated with the Toronto General Hospital of the University Health Network.
Phone: 416 340 4636